ES2052583T3 - Derivados de peptidos relacionados con el gel calcitonina. - Google Patents
Derivados de peptidos relacionados con el gel calcitonina.Info
- Publication number
- ES2052583T3 ES2052583T3 ES87310695T ES87310695T ES2052583T3 ES 2052583 T3 ES2052583 T3 ES 2052583T3 ES 87310695 T ES87310695 T ES 87310695T ES 87310695 T ES87310695 T ES 87310695T ES 2052583 T3 ES2052583 T3 ES 2052583T3
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- peptides related
- serum
- calcium
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000055006 Calcitonin Human genes 0.000 title 1
- 108060001064 Calcitonin Proteins 0.000 title 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title 1
- 229960004015 calcitonin Drugs 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57527—Calcitonin gene related peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
UN PEPTIDO DE FORMULA (1), EN LA QUE Y ES AZUFRE O METILENO Y A ES ASN O ASP, O UNA DE SUS SALES FISIOLOGICAMENTE ACEPTABLES; TIENE ACTIVIDAD DE DSIMINUCION DEL CALCIO EN EL SUERO Y ACTIVIDAD DE DISMINUCION DE FOSFATO EN EL SUERO, Y POR ELLO SE PUEDE UTILIZAR EN EL TRATAMIENTO DE DESORDENES METABOLICOS DE CALCIO, ENFERMEDADES CARDIACAS Y ULCERAS POR MEJORA DEL SISTEMA CIRCULATORIO DEL CEREBRO.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28959786 | 1986-12-04 | ||
| JP31058586 | 1986-12-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2052583T3 true ES2052583T3 (es) | 1994-07-16 |
Family
ID=26557652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES87310695T Expired - Lifetime ES2052583T3 (es) | 1986-12-04 | 1987-12-04 | Derivados de peptidos relacionados con el gel calcitonina. |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US5049654A (es) |
| EP (1) | EP0270376B1 (es) |
| DE (1) | DE3782010T2 (es) |
| ES (1) | ES2052583T3 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
| EP0348490B1 (en) * | 1988-01-11 | 1995-09-27 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
| US5266561A (en) * | 1988-01-11 | 1993-11-30 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
| US5175145A (en) * | 1988-08-26 | 1992-12-29 | Amylin Pharmaceuticals, Inc. | Treatment of diabetes mellitus with amylin agonists |
| GB8829432D0 (en) * | 1988-12-15 | 1989-02-01 | Celltech Ltd | Enzymatic process |
| CA2020786A1 (en) * | 1989-07-10 | 1991-01-11 | Amylin Pharmaceuticals, Inc. | Treatment of obesity and essential hypertension and related disorders |
| US5688938A (en) * | 1991-08-23 | 1997-11-18 | The Brigham & Women's Hospital, Inc. | Calcium receptor-active molecules |
| US6313146B1 (en) | 1991-08-23 | 2001-11-06 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| US5763569A (en) * | 1991-08-23 | 1998-06-09 | The Brigham And Women's Hospital, Inc | Calcium receptor-active molecules |
| US6031003A (en) * | 1991-08-23 | 2000-02-29 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| US6011068A (en) * | 1991-08-23 | 2000-01-04 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| US5858684A (en) * | 1991-08-23 | 1999-01-12 | The Brigham And Women's Hospital, Inc. | Method of screening calcium receptor-active molecules |
| US6001884A (en) * | 1991-08-23 | 1999-12-14 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| US5962314A (en) * | 1993-02-23 | 1999-10-05 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| US5567679A (en) * | 1993-12-13 | 1996-10-22 | Daly; Theodore J. | Use of CGRP in treating alopecia |
| CN1147459C (zh) | 1994-10-21 | 2004-04-28 | Nps药物有限公司 | 钙受体活性化合物 |
| ATE430123T1 (de) | 1996-05-01 | 2009-05-15 | Nps Pharma Inc | Inorganische am ionen-rezeptor aktive verbindungen |
| SK15352000A3 (sk) * | 1998-04-15 | 2001-04-09 | Aventis Pharmaceuticals Products Inc. | Spôsob výroby cyklických peptidov viazaných k polymérnemu nosiču |
| CA2292902C (en) * | 1999-12-24 | 2012-12-18 | Alain Cadieux | Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases |
| AU2006214233A1 (en) | 2005-02-17 | 2006-08-24 | Wyeth | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4514331A (en) * | 1983-06-29 | 1985-04-30 | University Patents, Inc. | Peptide hormones with calcitonin-like activity |
| JPS62129297A (ja) * | 1985-08-09 | 1987-06-11 | Toyo Jozo Co Ltd | カルシトニン遺伝子関連ペプチド誘導体 |
-
1987
- 1987-12-04 DE DE8787310695T patent/DE3782010T2/de not_active Expired - Fee Related
- 1987-12-04 US US07/128,950 patent/US5049654A/en not_active Expired - Fee Related
- 1987-12-04 ES ES87310695T patent/ES2052583T3/es not_active Expired - Lifetime
- 1987-12-04 EP EP87310695A patent/EP0270376B1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0270376A2 (en) | 1988-06-08 |
| EP0270376B1 (en) | 1992-09-30 |
| DE3782010T2 (de) | 1993-02-18 |
| EP0270376A3 (en) | 1990-02-07 |
| DE3782010D1 (de) | 1992-11-05 |
| US5049654A (en) | 1991-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2052583T3 (es) | Derivados de peptidos relacionados con el gel calcitonina. | |
| ATE113208T1 (de) | Verwendung des wirkstoffs azelastin zur bekämpfung von psoriasis-erkrankungen. | |
| ATE308336T1 (de) | Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten | |
| MX9203543A (es) | Medicamento. | |
| DK215287A (da) | Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette | |
| RU95106651A (ru) | Аналоги дзе-тур динорфина и способ лечения толерантных состояний у пациента | |
| SE8802569L (sv) | Foerbaettringar vid eller avseende somatosstatiner | |
| DE3688038D1 (de) | Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst. | |
| IT8619055A0 (it) | Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli statidi shock e dell'insufficienza respiratoria e cardiocircolatoria. | |
| ES2061823T3 (es) | Nueva proteina h que es capaz de fijarse a igg, gen que codifica dicha proteina h, y un procedimiento para producir dicha proteina h. | |
| IT8322855A0 (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche. | |
| BR9007115A (pt) | Novo trombolitico | |
| PT85454A (de) | Verwendung von 15-deoxyspergualin als arzneimittel | |
| ATA188385A (de) | Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen | |
| NO167144C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktiv imidazo (4,5-f) isokinolin-2-on. | |
| ATE87482T1 (de) | Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen. | |
| NO161494C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive benzodiazepiner. | |
| NO164100C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer. | |
| DK301489A (da) | Cgrp til anvendelse til forbedring cerebral blodtilfoersel | |
| IT8419940A0 (it) | Nuovi medicinali per il trattamento di malattie cardiache. | |
| DE3851669D1 (de) | Verwendung von Gepiron für Medikamente zur Milderung panischer Zustände. | |
| IT1145861B (it) | Sistema di tissaggio contemporaneo della suola sul tacco e del sotto tacco al tacco | |
| IT8621261A0 (it) | Composizioni farmaceutiche per la terapia di stati fisiopatologici ad accresciuto catabolismo proteico. | |
| IT8635931V0 (it) | Perfezionamento del controllore dell'iniezione di gocce medicinali | |
| FR2584605B1 (fr) | Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 270376 Country of ref document: ES |